Great West Life Assurance CO Celldex Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,338 shares of CLDX stock, worth $159,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,338
Previous 13,617
53.46%
Holding current value
$159,337
Previous $505,000
57.43%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$232 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$97.3 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$86.9 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$83.8 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.18B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...